• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Doug Kass
    • Bruce Kamich
    • Jim Cramer
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • Trifecta Stocks
  1. Home
  2. / Investing

Thermo Fisher Scientific Could Trade Higher in the Weeks and Months Ahead

The charts of TMO are positive.
By BRUCE KAMICH
Jan 29, 2020 | 02:50 PM EST
Stocks quotes in this article: ADPT, DHR, TMO

Tuesday night's fast-paced 'Lightning Round' segment of Mad Money had one caller asking about Adaptive Biotechnologies (ADPT) : "I like Danaher (DHR) more and I like Thermo Fisher Scientific (TMO) more," said Jim Cramer.

ADPT does not have much trading history to work with (chart below) and only turned slightly constructive in recent days.

 
 
And we covered DHR recently, so let's check out TMO.  
 
In this daily bar chart of TMO, below, we can see that prices have moved higher in an uptrend the past year. Prices are above the rising 50-day moving average line and above the rising 200-day moving average line.
 
Trading volume looks like it has decreased since early October but the daily On-Balance-Volume (OBV) line shows a nice rise for the year. A rising OBV line tells us that buyers of the stock have been more aggressive.
 
The Moving Average Convergence Divergence (MACD) oscillator turned positive in late October and looks like it could soon turn upwards to a fresh buy signal. 
 
 
In this weekly bar chart of TMO, below, we can see a three-year uptrend where prices have more than doubled. TMO is above the rising 40-week moving average line.
 
The weekly OBV line has been strong since the middle of 2018 and the MACD oscillator is bullish.
 
 
 
In this Point and Figure chart of TMO, below, we can see a potential upside price target of around $367. 
 
 
Bottom line strategy: The charts of TMO are positive. Trade from the long side risking a close below $320. $367 is our Point and Figure target.
Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

Employess of TheStreet are prohibited from trading individual securities.

TAGS: Investing | Stocks | Technical Analysis | Trading | Healthcare | Technology | Mad Money

More from Investing

Twitter's Charts Get a New Life but the Candles Suggest Caution

Bruce Kamich
Feb 26, 2021 10:31 AM EST

I'm reluctant to probe the long side at this point in time.

What's Driving NL Industries Stock Higher?

Jonathan Heller
Feb 26, 2021 10:30 AM EST

NL currently garners no analyst coverage, which is one of the reasons that you've likely never heard of the company.

Airbnb May Not Be So Hospitable in the Weeks Ahead

Bruce Kamich
Feb 26, 2021 9:31 AM EST

Stand aside for now.

NovoCure Has Broken Down on the Charts: What to Do Now

Bruce Kamich
Feb 26, 2021 9:10 AM EST

Our latest analysis and trading strategy on NVCR.

It's the Fed vs. the U.S. Bond Markets Now!

Maleeha Bengali
Feb 26, 2021 9:00 AM EST

All eyes will be on the Fed during their March FOMC meeting. It remains to be seen what they do next.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 12:31 PM EST PETER WILLSON

    Has the Short-Term Top Come for the XLF/Banks?

    The has triggered a long-term overbought signal ...
  • 10:10 AM EST GARY BERMAN

    DLTR: The Buck Might Not Stop Here, but I Am Looking for a Bounce

    Dollar Tree is trading inside our long-term boun...
  • 08:36 AM EST GARY BERMAN

    Wednesday Morning Fibocall for 2/24/2021

    SPX (Long-Term View) The 2/16 HIGH @ 3950.43 is ...
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2021 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login